HIV/AIDS

Data suggest that some gay and other men who have sex with men are using antiretroviral medications without a prescription.

Despite effective cART, HIV can hide in the spleen of patients with no detectable HIV in the blood.

The once-daily tablet regimen was approved for the treatment of HIV-1 infection. It is the smallest INSTI-based triple-therapy STR available.

A new study finds patients can achieve long-term reductions in depressive symptoms through tele-psychotherapy.

Almost half of new HIV diagnoses in the US are African-American patients. Where is the root of the issue?

Combination ART has dramatically improved survival rates among those living with HIV and is a mainstay of HIV prevention.

School-based sex education incorporating relevant information on condom use, PrEP and elevated HIV risk could reduce sexual risk behaviors and HIV transmission.

A review of more than 75 studies has revealed a link between persistent T cell activation and multiple risk factors for CVD.

The therapy is approved for the treatment of HIV-1 infection in adults and pediatric patients ages 12 years and older.

A review of antidepressants' impact on PLWH with depression suggested that they should be utilized for patients with HIV—a population at high risk for depression.

The international study will compare the World Health Organization's recommended regimen against 2 others.

All regions included in the analysis experienced notable increases in pretreatment NNRTI resistance each year.

New research investigating a novel means to eradicate HIV found a significant roadblock on the way to a cure.

Patients living with HIV and another comorbidity demonstrated higher ART adherence than adherence for their comorbid condition.

More difficult-to-get infections may be tracked better through social and risk networks.

New research shows patients who briefly stop taking antiretroviral therapy in order to participate in HIV trials don’t suffer any long-term damage.

Researchers from Stanford University have developed an HIV test that could increase testing rates, and thus treatment rates.

Samples of the female genital tracts of women infected with HIV show that the virus loses much of its genetic diversity by the time it hits the bloodstream.

A new meta-analysis suggests ART therapy has a positive impact on HPV and cervical cancer rates.

Jak inhibitors could represent an add-on therapy to existing antiretrovirals, addressing an unmet clinical need for HIV-infected individuals.

The study demonstrated proof-of-concept, demonstrating a sustained delivery system of 3 highly-potent antiretroviral therapies and drug-polymer matrices.

Researchers in Canada say a viral therapy developed to target cancer cells can also be used to target latent HIV-infected cells.

Findings could lead to the development of an approach allowing for a safe, lifelong immunity to HIV.